Chargement en cours...
Augmenting extinction learning with d-cycloserine reduces return of fear: a randomized, placebo-controlled fMRI study
d-cycloserine (DCS), a partial NMDA-receptor agonist, seems to be a promising enhancer for exposure therapy in anxiety disorders. It has been tested successfully in animal models of fear extinction, where DCS enhanced extinction learning. Applied in clinical studies, results of DCS-augmented exposur...
Enregistré dans:
| Publié dans: | Neuropsychopharmacology |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer International Publishing
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6969173/ https://ncbi.nlm.nih.gov/pubmed/31634897 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-019-0552-z |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|